Vicor (NASDAQ: VICR) posts strong Q1 2026 growth with 20% revenue gain and 75% backlog surge
Rhea-AI Filing Summary
Vicor Corporation reported strong first quarter 2026 results with higher revenue and profits. Net revenues rose to $113.0 million, up 20.2% from $94.0 million a year earlier and 5.3% above the fourth quarter of 2025, driven by product and royalty growth.
Gross margin reached $62.4 million, or 55.2% of revenue, up from 47.2% a year ago. Net income climbed to $20.7 million, or $0.44 per diluted share, versus $2.5 million, or $0.06, a year earlier, though below the prior quarter, which benefited from a $27.3 million tax item.
Operating cash flow was a use of $(3.9) million, reflecting a $28.6 million litigation award payment, while capital expenditures increased to $12.4 million as the company invests in manufacturing capacity. Cash and cash equivalents were $404.2 million and backlog surged to $301 million, 75% above the prior year.
Positive
- Revenue and profit acceleration: Net revenues grew 20.2% year over year to $113.0 million and net income rose to $20.7 million from $2.5 million, showing substantial operating leverage.
- Backlog and demand strength: Backlog reached $301 million, up 75% year over year and 70% sequentially, signaling strong visibility for future revenue across Vicor’s end markets.
Negative
- Operating cash outflow and litigation payment: Operating activities used $(3.9) million of cash in the quarter, reflecting a material $28.6 million payment of a past litigation award, alongside significantly higher capital expenditures.
Insights
Vicor delivered strong Q1 growth, expanding margins and backlog while investing heavily in capacity.
Vicor grew net revenues to $113.0 million, up 20.2% year over year, with gross margin rising to 55.2%. Net income increased to $20.7 million from $2.5 million, highlighting strong operating leverage even after higher R&D and modestly higher SG&A.
Backlog jumped to $301 million, a 75% year-over-year increase, indicating robust demand across target markets. Management is responding with higher capital expenditures of $12.4 million in the quarter and expanding fabrication capacity, which may support future revenue if demand persists.
Operating cash flow was negative $(3.9) million, driven by a $28.6 million litigation award payment, while cash ended at $404.2 million as of March 31, 2026. This combination of strong earnings, growing backlog, and substantial liquidity, alongside elevated investment, is a notably constructive setup for the business.